Hepion Pharmaceuticals, Inc. - Common Stock (HEPA)

Last Price0.2935

Change+0.0041 (1.42%)

NASDAQ · Last Trade: Apr 29th, 10:12 PM EDT

Hepion Pharmaceuticals (NASDAQ: HEPA) Reports Promising Phase 2 Trial Results for NASH Treatment

Renocofilstat's Positive Outcomes Reinforce Antifibrotic Action Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focusing on AI-assisted therapeutic drug development, recently

Via Spotlight Growth · May 22, 2023